Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 230

1.

The programmed death-1 ligand 1:B7-1 pathway restrains diabetogenic effector T cells in vivo.

Paterson AM, Brown KE, Keir ME, Vanguri VK, Riella LV, Chandraker A, Sayegh MH, Blazar BR, Freeman GJ, Sharpe AH.

J Immunol. 2011 Aug 1;187(3):1097-105. doi: 10.4049/jimmunol.1003496.

2.

Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.

Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H Jr, Sayegh MH, Najafian N.

J Immunol. 2005 Jun 1;174(11):6648-56.

3.

Protective role of programmed death 1 ligand 1 (PD-L1)in nonobese diabetic mice: the paradox in transgenic models.

Wang CJ, Chou FC, Chu CH, Wu JC, Lin SH, Chang DM, Sytwu HK.

Diabetes. 2008 Jul;57(7):1861-9. doi: 10.2337/db07-1260.

4.

Tissue expression of PD-L1 mediates peripheral T cell tolerance.

Keir ME, Liang SC, Guleria I, Latchman YE, Qipo A, Albacker LA, Koulmanda M, Freeman GJ, Sayegh MH, Sharpe AH.

J Exp Med. 2006 Apr 17;203(4):883-95.

5.

LAG-3, TGF-β, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L.

Lucas CL, Workman CJ, Beyaz S, LoCascio S, Zhao G, Vignali DA, Sykes M.

Blood. 2011 May 19;117(20):5532-40. doi: 10.1182/blood-2010-11-318675.

6.

Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice.

Yadav D, Hill N, Yagita H, Azuma M, Sarvetnick N.

Cell Immunol. 2009;258(2):161-71. doi: 10.1016/j.cellimm.2009.04.006.

PMID:
19497561
7.

Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.

Lucas JA, Menke J, Rabacal WA, Schoen FJ, Sharpe AH, Kelley VR.

J Immunol. 2008 Aug 15;181(4):2513-21.

9.

Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.

Won TJ, Jung YJ, Kwon SJ, Lee YJ, Lee DI, Min H, Park ES, Joo SS, Hwang KW.

Arch Pharm Res. 2010 Nov;33(11):1825-33. doi: 10.1007/s12272-010-1115-3.

PMID:
21116786
10.

Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.

Kanai T, Totsuka T, Uraushihara K, Makita S, Nakamura T, Koganei K, Fukushima T, Akiba H, Yagita H, Okumura K, Machida U, Iwai H, Azuma M, Chen L, Watanabe M.

J Immunol. 2003 Oct 15;171(8):4156-63.

11.

Dual control of antitumor CD8 T cells through the programmed death-1/programmed death-ligand 1 pathway and immunosuppressive CD4 T cells: regulation and counterregulation.

Currie AJ, Prosser A, McDonnell A, Cleaver AL, Robinson BW, Freeman GJ, van der Most RG.

J Immunol. 2009 Dec 15;183(12):7898-908. doi: 10.4049/jimmunol.0901060.

12.

Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway.

Haspot F, Fehr T, Gibbons C, Zhao G, Hogan T, Honjo T, Freeman GJ, Sykes M.

Blood. 2008 Sep 1;112(5):2149-55. doi: 10.1182/blood-2007-12-127449.

13.

The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice.

Ansari MJ, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, Yamazaki T, Azuma M, Iwai H, Khoury SJ, Auchincloss H Jr, Sayegh MH.

J Exp Med. 2003 Jul 7;198(1):63-9.

14.

PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells.

Latchman YE, Liang SC, Wu Y, Chernova T, Sobel RA, Klemm M, Kuchroo VK, Freeman GJ, Sharpe AH.

Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10691-6.

15.

Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

Fife BT, Guleria I, Gubbels Bupp M, Eagar TN, Tang Q, Bour-Jordan H, Yagita H, Azuma M, Sayegh MH, Bluestone JA.

J Exp Med. 2006 Nov 27;203(12):2737-47.

16.

Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade.

Reynoso ED, Elpek KG, Francisco L, Bronson R, Bellemare-Pelletier A, Sharpe AH, Freeman GJ, Turley SJ.

J Immunol. 2009 Feb 15;182(4):2102-12. doi: 10.4049/jimmunol.0802769.

17.

Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.

Ritprajak P, Hashiguchi M, Tsushima F, Chalermsarp N, Azuma M.

J Immunol. 2010 May 1;184(9):4918-25. doi: 10.4049/jimmunol.0902478.

18.

Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.

Yamazaki T, Akiba H, Koyanagi A, Azuma M, Yagita H, Okumura K.

J Immunol. 2005 Aug 1;175(3):1586-92.

19.

Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.

Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH.

J Clin Invest. 2007 Oct;117(10):2974-82.

20.

Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.

Bu DX, Tarrio M, Maganto-Garcia E, Stavrakis G, Tajima G, Lederer J, Jarolim P, Freeman GJ, Sharpe AH, Lichtman AH.

Arterioscler Thromb Vasc Biol. 2011 May;31(5):1100-7. doi: 10.1161/ATVBAHA.111.224709.

Items per page

Supplemental Content

Support Center